Bristol Myers Squibb

AstraZeneca holds talks with Bristol Myers Squibb on US$400 billion megadeal

2026-08-02T21:51:26.000Z
Bristol, with its settlement, is not admitting liability for declining a request from a prescription supplier to make a copycat version of an anti-cancer drug.

Bristol Myers to pay 10 million shekels to settle Israel anti-competition charges

2024-07-01T14:33:49.000Z